Petróleo Brasileiro S.A. - Petrobras (0KHP)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 26.23 |
|---|---|
| 52-week range | 11.48 – 26.39 |
| Return, 1 month / 3 months | +24.4% / +41.2% |
| Return, 1 year / 3 years | +137.9% / +137.7% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 34.7% |
| Worst drawdown (1 year) | -26.9% |
| Average daily value traded | 1.15M USD |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Petróleo Brasileiro S.A., known as Petrobras, is a Brazilian energy company controlled by the state. It explores for and produces crude oil and natural gas, largely from deep-water offshore fields, and operates refineries that turn crude into fuels, lubricants and other petroleum products. It sells fuels and related products to distributors, industrial customers and consumers in Brazil and abroad, and it also generates and trades electricity and produces petrochemicals and fertilisers.
Petróleo Brasileiro S.A. - Petrobras trades under the code 0KHP on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Petróleo Brasileiro S.A. - Petrobras (0KHP) trades on the London Exchange in UK. It last closed at USD 26.23 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 338 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 137.9% and over the last three months it rose 41.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 43.3% | ||
| From 52-week high | 0.0% | ||
| Momentum | 93 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 41.2% | ||
| 6-month return | 28.6% | ||
| 12-month return, skipping the last month | 91.3% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.9% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.15M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | +24.4% |
| 3 months | +41.2% |
| 6 months | +28.6% |
| 1 year | +137.9% |
| 3 years | +137.7% |
| 5 years | +715.2% |
Signals
| 50-day / 200-day average | 21.59 / 18.31 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Aug 2026 | BRL 0.4410 |
| 3 Jun 2026 | BRL 0.2254 |
| 24 Apr 2026 | BRL 0.1948 |
| 26 Dec 2025 | BRL 0.3081 |
| 25 Aug 2025 | BRL 0.2112 |
| 4 Jun 2025 | BRL 0.2806 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.